Brain Monitoring Devices Market Summary

• The brain monitoring devices market was valued at USD 5.89 billion in 2024, growing at a CAGR of 7.27% during the forecast period from 2024 to 2032, to reach USD 9.13 billion by 2032.
• The brain monitoring devices market is experiencing significant growth due to the increasing instances of neurological disorders such as multiple sclerosis and epilepsy, and dementia, coupled with increasing awareness of these disorders, and rising product developmental activities are acting as major factors contributing to the overall growth of the brain monitoring devices market during the forecast period from 2024 to 2032.
• Brain Monitoring Devices companies working in the brain monitoring devices market are Medtronic, Nonin, Raumedic AG, Natus Medical Incorporated, Edwards Lifesciences Corporation, BrainScope Company Inc., NIHON KOHDEN CORPORATION, Neurosoft, Advanced Brain Monitoring Inc., Rimed, Masimo, NeuroWave Systems Inc., Compumedics Limited, Spiegelberg GmbH & Co. KG, NOVASIGNAL CORPORATION, and others.

Brain Monitoring Devices Market Size and Forecast

• 2024 Market Size: USD 5.89 billion
• 2032 Projected Market Size: USD 9.13 billion
• Growth Rate (2025-2032): 7.27% CAGR
• Largest Market: North America
• Fastest Growing Market: Asia-Pacific
• Market Structure: Moderately Consolidated

Brain Monitoring Devices by Product Type (Electroencephalography Devices, Magnetoencephalography Devices, Electromyography Devices, Transcranial Ultrasound Doppler, Intracranial Pressure Monitoring Devices, and Others), Brain Monitoring Devices by Device Type (Invasive and Non-Invasive), Brain Monitoring Devices by Application (Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Stroke, and Others), Brain Monitoring Devices by End-User (Hospitals, Diagnostic Centers, and Others), and Brain Monitoring Devices by Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing instances of neurological disorders and the rising product developmental activities across the globe

Factors Contributing to Brain Monitoring Devices Market Growth

Rising Neurological Disorders

Increasing prevalence of epilepsy, stroke, Alzheimer's, Parkinson's, and traumatic brain injuries drives demand for continuous, accurate monitoring solutions.

Aging Population Worldwide

Expanding elderly demographic heightens risk of neurodegenerative conditions, boosting need for routine brain health assessment and management.

Technological Advancements

Innovations in EEG, MEG, AI analytics, wireless sensors, and wearable/portable devices improve accuracy, portability, and real-time data processing.

Telemedicine and Remote Monitoring Adoption

Growth of cloud-based platforms and wireless systems enables home-based and remote neurological surveillance, enhancing accessibility.

Non-Invasive Device Preference

Shift toward EEG, fNIRS, and cerebral oximeters over invasive methods offers patient comfort, reduced risks, and broader clinical utility.

Healthcare Infrastructure Expansion

Investments in emerging markets like Asia-Pacific improve hospital capabilities and neurocritical care units equipped with advanced monitoring.

Research and Clinical Trial Demand

Surging neuroscience studies, brain-computer interfaces, and drug trials require sophisticated tools for precise brain activity tracking.

What are the Latest Brain Monitoring Devices Market Dynamics and Trends?

As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord. Brain monitoring devices are used to assess by tracking changes in brain activity and function. These devices help in diagnosing the condition, monitoring disease progression, and evaluating the effectiveness of treatments. They provide valuable insights into cognitive, emotional, motor, sensory, and visual impairments caused by MS, enabling more personalized and effective care.

Data from the WHO stated that in 2024, around 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. It is estimated that up to 70% of people living with epilepsy could have lived seizure-free if they had been properly diagnosed and treated. Additionally, globally, an estimated 5 million people are diagnosed with epilepsy each year. In high-income countries, there were estimated to be 49 per 100,000 people diagnosed with epilepsy each year, whereas in low- and middle-income countries, this figure could have been as high as 139 per 100,000. Brain monitoring devices are used to diagnose epilepsy, track seizure activity, and guide treatment plans. They help in monitoring brain function, assessing response to therapies, and improving the management of the condition.

According to data from the WHO (2023), it stated that more than 55 million people had dementia worldwide, with over 60% living in low- and middle-income countries. Each year, there were nearly 10 million new cases. Brain monitoring devices are used in dementia management to track changes in brain function, assess disease progression, and evaluate treatment effectiveness. They help in early detection and diagnosis by identifying abnormal brain activity patterns associated with dementia. These devices can monitor cognitive decline and support personalized treatment plans, aiming to improve patient care and quality of life.

Hence, the interplay of all the above-mentioned factors is expected to drive the brain monitoring devices market during the given forecast period from 2025 to 2032.

However, the availability of alternative monitoring options and others may restrict the market growth for the brain monitoring devices market.

Brain Monitoring Devices Market Segment Analysis:

Brain Monitoring Devices by Product Type (Electroencephalography Devices, Magnetoencephalography Devices, Electromyography Devices, Transcranial Ultrasound Doppler, Intracranial Pressure Monitoring Devices, and Others), Brain Monitoring Devices by Device Type (Invasive and Non-Invasive), Brain Monitoring Devices by Application (Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Stroke, and Others), Brain Monitoring Devices by End-User (Hospitals, Diagnostic Centers, and Others), and Brain Monitoring Devices by Geography (North America, Europe, Asia-Pacific, and Rest of the World) 

In the product type segment of the brain monitoring devices market, the electroencephalography devices category is expected to have a significant revenue share in the year 2025. This is due the numerous advantages and applications in brain monitoring offered by electroencephalography (EEG) devices.

One of its key feature is their ability to provide real-time, non-invasive monitoring of electrical activity in the brain, allowing for the detection of abnormalities such as epileptic seizures, sleep disorders, and brain wave irregularities. EEGs are widely used in diagnosing and managing neurological conditions like epilepsy, where they help identify seizure types and patterns crucial for effective treatment planning. They are also valuable in sleep studies, offering insights into sleep stages and disorders. 

Additionally, EEG devices play a significant role in cognitive research, helping to understand brain function and connectivity. Their applications extend to brain-computer interfaces, where they facilitate communication and control for individuals with severe motor impairments. Technological advancements such as the launch of wireless EEG systems where in long-term EEG studies can be carried out have also contributed in the rising popularity of these devices among healthcare providers.

Rising product developmental strategies by key Brain Monitoring Devices players are also slated to push forward the revenue shares for the same. For example in May 2024, Soterix Medical introduced the MxN-GO EEG system, which combines high-definition transcranial electrical stimulation (HD-tES) with EEG functionalities. This system is intended to support research that involves both electrical brain stimulation and activity recording in real-world, mobile environments.

Therefore, the widespread uses and various advantages of electroencephalography devices enhance performance and usability, solidifying a significant impact on the growth of the overall brain monitoring devices market during the forecast period from 2025 to 2032.

Recent Developmental Activities in the Brain Monitoring Devices Market:

• In January 2026, FDA cleared Naox Technologies' Naox Link, the first in-ear EEG device for extended real-world brain monitoring.
• In January 2026, FDA granted Breakthrough Device Designation to Ceribell's LVO stroke detection and monitoring solution using AI on EEG signals; also cleared proprietary delirium screening solution in December 2025.
• In February 2025, FDA approved Medtronic's Adaptive Deep Brain Stimulation (aDBS) system with BrainSense Electrode Identifier for Parkinson's disease patients.
• In March 2025, FDA cleared QuantalX Neuroscience's Delphi-MD stimulator for direct brain health diagnosis, including detection of stroke, dementia, and NPH risks.
• In May 2025, Natus Medical introduced BrainWatch point-of-care EEG solution.
• In December 2025, FDA granted 510(k) clearance to Natus Medical's BrainWatch for electrographic status epilepticus detection and diagnosis.

Brain Monitoring Devices Market Regional Analysis

North America Brain Monitoring Devices Market Trends

Among all the regions, North America Brain Monitoring Devices Market is estimated to hold a significant revenue share in the brain monitoring devices market. This can be attributed to several factors, including the growing burden of Parkinson's disease, the increasing prevalence of brain injuries caused by trauma, and ongoing product development activities by regulatory authorities supported by the presence of key Brain Monitoring Devices players in the region that contribute to the growth of the brain monitoring devices market in the North America region during the forecast period from 2024 to 2032.

Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2032. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the U.S. Brain monitoring devices are used to track and assess brain activity in individuals with Parkinson's disease. They help in diagnosing the condition, monitoring disease progression, and evaluating the effectiveness of treatments. These devices provide valuable insights into motor symptoms and cognitive function, aiding in personalized care and the development of targeted therapies.

According to data provided by the Centre for Disease Control and Prevention (2024), in 2021, there were more than 586 traumatic brain injury-related hospitalizations per day in the US. Traumatic brain injuries, caused by head trauma from accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and guide treatment decisions. Brain monitoring devices are used in the context of traumatic brain injuries to provide crucial insights for diagnosis and treatment. These devices help in assessing the severity of brain damage caused by head trauma from accidents, falls, or sports injuries. They facilitate real-time monitoring of brain activity, enabling accurate evaluation of the injury's impact and guiding timely and appropriate treatment decisions. By continuously tracking brain function, these devices support effective management and rehabilitation of brain monitoring device patients.

Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of brain monitoring devices in the region. For example, in March 2021, Brain Scientific Inc received a 510(k) clearance for its next generation NeuroCap™ device. This device is an advanced Electroencephalogram (EEG) electrode array which is employed in routine clinical and research settings to obtain rapid EEGs where STAT EEG recordings are desired.

Moreover, the constant focus of market Brain Monitoring Devices manufacturers in targeting the region in product launches is further expected to propel the growth of the North America brain monitoring devices market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the brain monitoring devices market during the forecast period from 2024 to 2032.

Brain Monitoring Devices Companies:

Some of the key Brain Monitoring Devices manufacturers operating in the brain monitoring devices market include Medtronic, Nonin, Raumedic AG, Natus Medical Incorporated, Edwards Lifesciences Corporation, BrainScope Company Inc., NIHON KOHDEN CORPORATION, Neurosoft, Advanced Brain Monitoring Inc., Rimed, Masimo, NeuroWave Systems Inc., Compumedics Limited, Spiegelberg GmbH & Co. KG, NOVASIGNAL CORPORATION, and others.

Key takeaways from the Brain Monitoring devices market report study

• Brain Monitoring Devices Market size analysis for current brain monitoring devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key Brain Monitoring Devices companies dominating the brain monitoring devices market
• Various opportunities available for the other competitors in the brain monitoring devices market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current brain monitoring devices market scenario?
• Which are the regions and countries where Brain Monitoring Devices companies should have concentrated on opportunities for brain monitoring devices market growth in the coming future?

Target audience who can be benefited from this brain monitoring devices market report study

• Brain monitoring device providers
• Research organizations and consulting companies 
• Brain monitoring devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up Brain Monitoring Devices companies, venture capitalists, and private equity firms
• Distributors and traders dealing in brain monitoring devices 
• Various end-users who want to know more about the brain monitoring devices market and the latest developments in the brain monitoring devices market

Get detailed insights @ DelveInsight Blogs